Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
OMG Americas, formerly a primary operating subsidiary of OM Group, was a leading specialty chemicals company that provided critical metal-based intermediates and catalysts to the pharmaceutical and life sciences industries. The company specialized in the production of high-purity metal carboxylates and inorganic salts used as catalysts in the synthesis of active pharmaceutical ingredients (APIs) and as essential nutrients in the production of vitamins, such as Vitamin B12. Additionally, through its ownership of EaglePicher Technologies, the company was a significant provider of medical power solutions, including specialized batteries for implantable devices like pacemakers and defibrillators. Following the acquisition of OM Group by Apollo Global Management in 2015, the company's various divisions were divested or merged into other entities, with the specialty chemicals business eventually becoming part of Vibrantz Technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on OMG Americas.